Royal Bank of Canada
PTLA

Royal Bank of Canada’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Royal Bank of Canada’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-80,000
Closed -$2.17M – 7379
2019
Q2 		$2.17M Buy
+80,000
New +$2.51M ﹤0.01% 2692

Royal Bank of Canada's PTLA Position: Q3 2020 in Review

Royal Bank of Canada sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 301,185 shares — an estimated $5.42M sold.

Royal Bank of Canada first reported a position in PTLA in Q3 2013 and held it in 26 quarters. The position peaked at $5.42M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

  • Royal Bank of Canada reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 301,185 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $5.42M.
  • Royal Bank of Canada first reported a position in Portola Pharmaceuticals, Inc. in Q3 2013 and held it in 26 quarters.
  • Royal Bank of Canada's Portola Pharmaceuticals, Inc. position peaked at $5.42M in Q2 2020.
  • 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Royal Bank of Canada's 13F filing for Q3 2020, filed 16 Nov 2020.